|
iSonea accelerates commercialisation of asthma devices in US, in negotiations …
Proactive Investors Australia They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is currently in negotiations with major strategic partners to accelerate commercialisation and cash flows of its next generation asthma products in … |
View full post on asthma – Google News